Gradient Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

Gradient Investments’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$2K	–	794
2017 Q2	$2K	Hold	100	–	–	﹤0.01%	705
2017 Q1	$2K	Hold	100	–	–	﹤0.01%	694
2016 Q4	$3K	Hold	100	–	–	﹤0.01%	606
2016 Q3	$2K	Hold	100	–	–	﹤0.01%	628
2016 Q2	$2K	Hold	100	–	–	﹤0.01%	628
2016 Q1	$2K	Hold	100	–	–	﹤0.01%	635
2015 Q4	$3K	Hold	100	–	–	﹤0.01%	565
2015 Q3	$4K	Hold	100	–	–	﹤0.01%	480
2015 Q2	$7K	Hold	100	–	–	﹤0.01%	431
2015 Q1	$5K	Hold	100	–	–	﹤0.01%	489
2014 Q4	$4K	Hold	100	–	–	﹤0.01%	441
2014 Q3	$3K	Hold	100	–	–	﹤0.01%	400
2014 Q2	$2K	Hold	100	–	–	﹤0.01%	445
2014 Q1	$2K	Buy	+100	New	+$2.12K	﹤0.01%	462

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Gradient Investments's AMAG Position: Q3 2017 in Review

Gradient Investments sold out of AMAG Pharmaceuticals (AMAG) in Q3 2017, closing a stake of 100 shares — an estimated $2K sold.

Gradient Investments first reported a position in AMAG in Q1 2014 and held it in 14 quarters. The position peaked at $7K in Q2 2015. 187 funds tracked by Wall St. Rank hold AMAG as of Q3 2017.

Gradient Investments reported no remaining AMAG Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Gradient Investments sold 100 AMAG Pharmaceuticals shares in Q3 2017, an estimated $2K.
Gradient Investments first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 14 quarters.
Gradient Investments's AMAG Pharmaceuticals position peaked at $7K in Q2 2015.
187 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2017.

Based on Gradient Investments's 13F filing for Q3 2017, filed 16 Oct 2017.